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transcriptional control of e-NOS (i.e. mRNA) is not impaired and appears to be upregu- 
latod in the presence of vascular dysfunction. Measurement of tissue expression of 
mRNA for e-NOS is a novel indicator of vascular dysfunction that may be helpful in 
mechanistic studies. 
1056-81 The Combination of Renin-Angiotensin System 
Inhibitors and HMG-CoA Reductaee Inhibitore in 
Atherosclerosis: Effects on Vascular Endothelial 
Function 
Bobbv V. Khan, Wright B. Lauten, Syed T. Rahman, Qamar A. Khan, Sampath 
Parthasa~'athy, Emory University School of Medicine, Atlanta, Georgia. 
Background: Endothelial dysfunction plays a fundamental role through which cardiovas- 
cular risk factors contribute to atherosclerosis. Severat pharmacological gents, including 
HMG-CoA reductase (HMGR) inhibitors and renin-angiotensin system (RAS) inhibitors, 
appear to possess cardioprotactive effects via mechanisms that may reverse vascular 
endothelial dysfunction in atherosclerosis. 
Methods: We studied t24 normotensive and hyperlipidemic patients with stable coro- 
nary artery disease on a medical regimen including aspirin (CON). The patients were 
treated with the HMGR inhibitor atorvastatin (ATO, 10-40 rag/day) to obtain a serum LDL 
cholesterol of <100 mg/dl. The subjects were then randomized to either of two RAS inhib- 
itors: the angiotensin converting enzyme inhibitor quinapril (QUI, n=65, 20 mg/day) or the 
angiotensin II type 1 receptor inhibitor irbesartan (IRB, n=59, 150 mg,'day) for 12 weeks. 
Results: Using ELISA analysis, treatment with ATO slightly reduced serum soluble vas- 
cular cell adhesion molecule-1 (sVCAM-1) levels from CON (CON: 433±72; ATO: 382±58 
ng/ml, p<0.084). Moreover, the addition of QUI or IRB reduced sVCAM-1 further by 33% 
and 36% respectively (both p<0.01 from CON and ATO). Also, treatment with ATO 
reduced serum soluble interleukin-6 (slL-6) by 17% (CON: 25.3_+3.3; ATO: 21.5+~.3 ng] 
ml, p<0.045); additional therapy with QUI or IRB reduced slL-6 by 29% and 40%, respec- 
tively (both p<0.01 from CON and ATO). Treatment with ATO did not significantly affect 
the adhesion of monocytes to the monoclonal antibody CD11b, a protein with high bind- 
ing affinity to human monocytes (CON: 75±11; ATO: 78±14 percent binding, NS). How- 
ever, the addition of QUI or IRB to ATO therapy dramatically suppressed monocyte 
binding to CD11b (QUI: 34±8; IRB: 27_+9 percent binding, both p<0.01 from CON or 
ATO). 
Conclusions: These findings suggest that HMGR inhibitors and RAS inhibitors have 
functions in addition to reductions in serum cholesterol and blood pressure. Furthermore, 
the combination of these agents may significantly reduce the effects and expression of 
vascular inflammatory and oxidative mechanisms in the pathogenesis of atherosclerosis. 
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Background: Endothelial shear stress (ESS) plays a critical role in atherogenesis: Low 
ESS increases production of inflammatory, growth, and adhesion molecules, and corre- 
lates with atherosclerosis. Ithas previously not been possible to predict sites of coronary 
disease (CAD) progression in vivo. The purpose of this study was to determine if CAD 
progression could be predicted in vivo based on ESS. Methods: We studied 4 patients at 
baseline and after 6 mos. The 3-D anatomy of an arterial segment with luminal obstruc- 
tion < 50% was determined using intracoronary ultrasound, biplane angiography, and 
coronary flow measurements. The lumen was reassembled in accurate 3-D space; local 
ESS was calculated using computational fluid dynamics. Outer vessel dimensions (exter- 
nal elastic lamina [EEL]) and the plaque (difference between EEL and the lumen) were 
similarly reconstructed. The techniques are highly reproducible. Changes in the artery at 
6 mos were assessed by general inear regression accounting for repeated measure- 
ments. Results: Baseline ESS ranged from 3-71 dynes/cm2. Low ESS was inversely 
associated with subsequent plaque progression (p<0.001); high ESS was associated 
with outward remodeling (p<0.01). Conclusions: These results show, for the first time in 
man, that sites of CAD progression over 6 mos can be identified in vivo. This methodol- 
ogy can detect minute changes in the coronary lumen, wall, and plaque and may be used 
to identify the natural history of CAD and the vascular esponse to therapies. 
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1056-83 Bradykinin B1 Receptor Gene Polymorphism is 
Associated With Impaired Coronary Reactivity in 
Women: A Report From the NHLBI WISE Study 
Zachary Brown, Richard A. Kerensky, Susan P. McGorray, Dennis M. McNamara, Staven 
E. Reis, C. Noel Bairey Merz, George Sopko, Cad J. Pepine, Daniel F. Pauly, University 
of Florida, Gainesville, University of Pittsburgh, Pennsylvania. 
Background: Bredykinin and related peptides (terminal kinins) promote vasoditation, 
endothelial NO production, and vascular permeability. Kinin fragments interact with 
bradykinin B1 receptors (B1R), which couple to G-proteins. We hypothesized that the 
kinin system's protective ffect on the coronary circulation may be reduced in patients 
with polymorphic (deficient) alleles of the B1 R gene. 
Methods: We studied 148 women enrolled in the NHLBI-sponsored Women's Ischemia 
Syndrome Evaluation (WISE). Women underwent quantitative coronary angiography 
(QCA) and genetic analysis for the G to C polymorphism at positior~ -699 of the gene. 
Seventy women underwent intracoronary Doppler flow studies. Volumetric flow was cal- 
culated from coronary cross sectional area (CSA) and flow velocity. Measurements were 
made at baseline and in response to adenosine, acetylcholine, and nitroglycedn. Flow 
ratios with each agent o flow at baseline were calculated. 
Results: Twenty-five women (20.3%) carried the B1 R gene polymorphism. Women car- 
rying the polymorphism (CG genotype) showed a significant decrease in response to 
adenosine. Their mean flow ratio was 2.05 ± 0.30, while "wildtype" women (GG geno- 
type) had a mean ratio of 2.78 ± 0.15 (p=0.047). This change in flow ratio was due to a 
decrease in velocity (p=0.022), rather than to a change in CSA (p=0.78). Similar results 
were obtained in response to nitroglycerin. Women with the polymorphism had flow ratio 
of 2.47 ± 0.24 versus 3.36 + 0.14 for the wildtype genotype (p=0.029). When acetylcho- 
line (an endothelial mediator) was tested, no difference was seen by genotype (p=0.55). 
No difference by genotype was seen for age, severity of angiographic oronary artery 
disease (CAD), hypertension, diabetes, dyslipidemia, or smoking, 
Conclusion: A polymorphism in the bradykinin B1R gene is associated with impaired 
coronary reactivity in women. This association occurs independently of angiographic 
CAD, coronary risk factors, and endothelial mediated response. While some have sug- 
gested that impaired coronary reactivity may be a feature of early atherosclerosis, our 
data suggest hat intrinsic genetic factors contribute to coronary smooth muscle reactiv- 
ity, as well. 
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BACKGROUND: Previous studies showed that atherosclerotic plaques preferentially 
develop at average low shear stress (SS) locations. SS is known to control umen dimen- 
sions under physiological variations. We hypothesized that in the development of athero- 
sclerosis outward remodeling, while preserving the lumen, is controlled by SS. 
METHODS: In 12 atherosclerotic patients, interventionally treated for coronary lumen 
narrowing, a non-treatad angiographically normal coronary artery (lumen stenosis <50%) 
was investigated with a combined ANGiegraphic and ivUS technique (ANGUS) to pro- 
vide true 3D lumen and vessel wall geometry. Segments in between side branches were 
selected, resulting in 22 segments. The 3D reconstruction served to calculate SS by 
computational fluid dynamics, inflow for the segments was selected to deliver an average 
SS of 15 dynes]cm2 in normal reference (ref) cross sections (minimal plaque area). 
Lumen area (LA) stanosis (AS) was defined as (LA -LAref) / LAref * 100%. SS and wall 
thickness (Th) data were measured at 16 different cimumferential locations. For each 
segment, data were averaged over all cross sections. Linear regression analysis was 
used to relate Th to SS (Th=a+b*SS). Two groups were compared based on AS (AS <- 
10% and AS >-10%). 
RESULTS: For preserved lumen areas (AS>-t0%, average AS = 0.01 being not different 
from 0, p=0.8) the slope (b) of the relationship between Th and SS was negative, indicat- 
ing shear stress control (N=14, b = -6.1"10-4 ±9.8"10-4 mJ/N : p=0.036). For AS<-10% 
no relationship was observed (N=8, b = 0.9"10-4± 5.2"10-4 m3/N, p=0.6). The slopes of 
both groups were also different (p=0.038). 
CONCLUSION:These data show for the first time in coronary arteries of patients that the 
lumen preservation isobtained by SS regulation. 
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